APYX vs. AMPY
APYX (Apyx Medical Corporation) and AMPY (Amplify Energy Corp.) are both stocks. APYX operates in Medical Devices (Healthcare), while AMPY operates in Oil & Gas E&P (Energy). Over the past 5 years, APYX returned -17.88%/yr vs -0.82%/yr for AMPY. At a 0.13 correlation, their price movements are largely independent.
Performance
APYX vs. AMPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, APYX achieves a 14.57% return, which is significantly higher than AMPY's -11.60% return.
APYX
- 1D
- -2.43%
- 1M
- -2.91%
- YTD
- 14.57%
- 6M
- 11.08%
- 1Y
- 100.50%
- 3Y*
- -18.10%
- 5Y*
- -17.88%
- 10Y*
- —
AMPY
- 1D
- -2.18%
- 1M
- -19.36%
- YTD
- -11.60%
- 6M
- -15.66%
- 1Y
- 10.38%
- 3Y*
- -14.48%
- 5Y*
- -0.82%
- 10Y*
- 21.16%
APYX vs. AMPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
APYX Apyx Medical Corporation | 14.57% | 121.52% | -39.69% | 11.97% | -81.75% | 78.06% | -14.89% | 6.28% |
AMPY Amplify Energy Corp. | -11.60% | -23.83% | 1.18% | -32.54% | 182.64% | 137.40% | -77.85% | -5.47% |
Correlation
The correlation between APYX and AMPY is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2019 | 0.13 |
The correlation between APYX and AMPY shifts across timeframes, from -0.03 (1 year) to 0.13 (all time), reflecting how their relationship changes across market environments.
Fundamentals
APYX:
-$0.30
AMPY:
$0.29
APYX:
2.22
AMPY:
0.72
APYX:
$55.83M
AMPY:
$228.78M
APYX:
$21.29M
AMPY:
$131.23M
APYX:
-$3.18M
AMPY:
$84.62M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
APYX vs. AMPY — Risk / Return Rank
APYX
AMPY
APYX vs. AMPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and Amplify Energy Corp. (AMPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| APYX | AMPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.99 | ||
| Sortino ratioReturn per unit of downside risk | +1.38 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.08 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | 2.76 | 0.27 | +2.49 |
| Martin ratioReturn relative to average drawdown | 6.65 | 0.62 | +6.02 |
Loading charts...
Drawdowns
APYX vs. AMPY - Drawdown Comparison
The maximum APYX drawdown since its inception was -94.99%, roughly equal to the maximum AMPY drawdown of -97.31%. Use the drawdown chart below to compare losses from any high point for APYX and AMPY.
Loading charts...
Drawdown Indicators
| APYX | AMPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.99% | -97.31% | +2.32% |
Max Drawdown (1Y)Largest decline over 1 year | -36.59% | -39.06% | +2.47% |
Max Drawdown (3Y)Largest decline over 3 years | -88.52% | -71.11% | -17.41% |
Max Drawdown (5Y)Largest decline over 5 years | -94.99% | -77.47% | -17.52% |
Max Drawdown (10Y)Largest decline over 10 years | — | -97.24% | — |
Current DrawdownCurrent decline from peak | -76.95% | -78.59% | +1.64% |
Average DrawdownAverage peak-to-trough decline | -57.05% | -66.42% | +9.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.18% | 16.85% | -1.67% |
Volatility
APYX vs. AMPY - Volatility Comparison
Apyx Medical Corporation (APYX) has a higher volatility of 24.99% compared to Amplify Energy Corp. (AMPY) at 13.42%. This indicates that APYX's price experiences larger fluctuations and is considered to be riskier than AMPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| APYX | AMPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 24.99% | 13.42% | +11.57% |
Volatility (6M)Calculated over the trailing 6-month period | 55.41% | 40.36% | +15.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 88.07% | 65.26% | +22.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 100.40% | 67.17% | +33.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 93.07% | 980.58% | -887.51% |
Dividends
APYX vs. AMPY - Dividend Comparison
Neither APYX nor AMPY has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
AMPY Amplify Energy Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.63% | 6.05% |
APYX Apyx Medical Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
APYX vs. AMPY - Financials Comparison
This section allows you to compare key financial metrics between Apyx Medical Corporation and Amplify Energy Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
APYX and AMPY have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
APYX has higher volatility (24.99%) compared to AMPY (13.42%). In terms of maximum drawdown, APYX dropped -94.99% vs AMPY's -97.31%.
APYX currently has the higher Sharpe Ratio (1.15 vs 0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for APYX and AMPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer